B Melander

859 total citations
13 papers, 724 citations indexed

About

B Melander is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Animal Science and Zoology. According to data from OpenAlex, B Melander has authored 13 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 7 papers in Animal Science and Zoology. Recurrent topics in B Melander's work include Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Pharmacological Effects and Assays (7 papers). B Melander is often cited by papers focused on Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Pharmacological Effects and Assays (7 papers). B Melander collaborates with scholars based in Sweden, Switzerland and United Kingdom. B Melander's co-authors include L. Wåhlander, S Larsson, G Boman, Annika Wallin, Thomas Sandström, N Svedmyr, L Rosenhall, CG Lofdahl, Peter Arvidsson and Thomas Wegener and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

B Melander

13 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Melander Sweden	11	572	569	130	65	56	13	724
Christopher Kalberg United States	15	912 1.6×	872 1.5×	23 0.2×	32 0.5×	39 0.7×	20	1.0k
W. Stricker United States	11	652 1.1×	821 1.4×	12 0.1×	434 6.7×	50 0.9×	14	1.0k
Sandra M. Gawchik United States	16	291 0.5×	723 1.3×	44 0.3×	589 9.1×	24 0.4×	28	894
N. Barnes United Kingdom	8	293 0.5×	425 0.7×	6 0.0×	106 1.6×	40 0.7×	15	533
R. Townley United States	7	245 0.4×	275 0.5×	8 0.1×	53 0.8×	38 0.7×	16	348
César Villarán United States	9	356 0.6×	410 0.7×	14 0.1×	95 1.5×	10 0.2×	11	462
R. Nave Germany	14	443 0.8×	449 0.8×	25 0.2×	109 1.7×	30 0.5×	41	722
E.G. Gross United States	7	161 0.3×	203 0.4×	8 0.1×	31 0.5×	29 0.5×	16	339
A Knight Canada	13	231 0.4×	305 0.5×	35 0.3×	162 2.5×	28 0.5×	17	460
J S Mann United Kingdom	9	137 0.2×	163 0.3×	9 0.1×	18 0.3×	44 0.8×	16	290

Countries citing papers authored by B Melander

Since Specialization

Citations

This map shows the geographic impact of B Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Melander more than expected).

Fields of papers citing papers by B Melander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Melander. The network helps show where B Melander may publish in the future.

Co-authorship network of co-authors of B Melander

This figure shows the co-authorship network connecting the top 25 collaborators of B Melander. A scholar is included among the top collaborators of B Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Melander. B Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wallin, Annika, Thomas Sandström, Peter Howarth, et al.. (1999). The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma. American Journal of Respiratory and Critical Care Medicine. 159(1). 79–86. 109 indexed citations

Ullman, A., et al.. (1996). Formoterol inhaled as dry powder or via pressurized metered‐dose inhaler in a cumulative dose‐response study. Allergy. 51(10). 745–748. 12 indexed citations

Stålenheim, Gunnemar, Thomas Wegener, Bo Lundbäck, et al.. (1994). Efficacy and Tolerance of a 12-Week Treatment with Inhaled Formoterol in Patients with Reversible Obstructive Lung Disease. Respiration. 61(6). 305–309. 9 indexed citations

Wallin, Annika, Thomas Sandström, L Rosenhall, & B Melander. (1993). Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.. Thorax. 48(6). 611–614. 59 indexed citations

Wegener, Thomas, Hans Hedenström, & B Melander. (1992). Rapid Onset of Action of Inhaled Formoterol in Asthmatic Patients. CHEST Journal. 102(2). 535–538. 47 indexed citations

Hedenström, Hans, Thomas Wegener, G Boman, L. Wåhlander, & B Melander. (1992). Effect of inhaled formoterol versus terbutaline on respiratory function in moderate bronchial asthma. Allergy. 47(2). 158–163. 12 indexed citations

Palmqvist, Mona, Barbro Balder, O. Löwhagen, et al.. (1992). Late asthmatic reaction decreased after pretreatment with salbutamol and formoterol, a new long-acting β2-agonist. Journal of Allergy and Clinical Immunology. 89(4). 844–849. 38 indexed citations

Midgren, Bengt, B Melander, & Gunnar Persson. (1992). Formoterol, a New Long-Acting ß2 Agonist, Inhaled Twice Daily, in Stable Asthmatic Subjects. CHEST Journal. 101(4). 1019–1022. 29 indexed citations

Arvidsson, Peter, S Larsson, CG Lofdahl, et al.. (1991). Inhaled formoterol during one year in asthma: a comparison with salbutamol. European Respiratory Journal. 4(10). 1168–1173. 82 indexed citations

10.

Wallin, Annika, B Melander, L Rosenhall, Thomas Sandström, & L. Wåhlander. (1990). Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.. Thorax. 45(4). 259–261. 68 indexed citations

11.

Arvidsson, Peter, S Larsson, CG Lofdahl, et al.. (1989). Formoterol, a new long-acting bronchodilator for inhalation. European Respiratory Journal. 2(4). 325–330. 77 indexed citations

12.

Boman, G, et al.. (1983). Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.. PubMed. 64(6). 405–15. 177 indexed citations

13.

Melander, B, et al.. (1957). Experimental and clinical evaluation of chlorcyclizine as an antitussive.. PubMed. 7(5). 301–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact